These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27376396)

  • 1. Insights into the structural patterns of the antileishmanial activity of bi- and tricyclic N-heterocycles.
    Herrera L; Stephens DE; D'Avila A; George KG; Arman H; Zhang Y; Perry G; Lleonart R; Larionov OV; Fernández PL
    Org Biomol Chem; 2016 Aug; 14(29):7053-60. PubMed ID: 27376396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, characterization, and antileishmanial activity of neutral N-heterocyclic carbenes gold(I) complexes.
    Zhang C; Bourgeade Delmas S; Fernández Álvarez Á; Valentin A; Hemmert C; Gornitzka H
    Eur J Med Chem; 2018 Jan; 143():1635-1643. PubMed ID: 29133045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmanicidal activity of some stilbenoids and related heterocyclic compounds.
    del Olmo E; Armas MG; López-Pérez JL; Muñoz V; Deharo E; San Feliciano A
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2123-6. PubMed ID: 11514152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, analytical behaviour and biological evaluation of new 4-substituted pyrrolo[1,2-a]quinoxalines as antileishmanial agents.
    Guillon J; Forfar I; Mamani-Matsuda M; Desplat V; Saliège M; Thiolat D; Massip S; Tabourier A; Léger JM; Dufaure B; Haumont G; Jarry C; Mossalayi D
    Bioorg Med Chem; 2007 Jan; 15(1):194-210. PubMed ID: 17049253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antileishmanial activities of dihydrochalcones from piper elongatum and synthetic related compounds. Structural requirements for activity.
    Hermoso A; Jiménez IA; Mamani ZA; Bazzocchi IL; Piñero JE; Ravelo AG; Valladares B
    Bioorg Med Chem; 2003 Sep; 11(18):3975-80. PubMed ID: 12927858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the Antileishmanial Activity of Gold(I) and Gold(III) Compounds in L. amazonensis and L. braziliensis in Vitro.
    Minori K; Rosa LB; Bonsignore R; Casini A; Miguel DC
    ChemMedChem; 2020 Nov; 15(22):2146-2150. PubMed ID: 32830445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the current status of privileged N-heterocycles as antileishmanial agents.
    Razzaghi-Asl N; Sepehri S; Ebadi A; Karami P; Nejatkhah N; Johari-Ahar M
    Mol Divers; 2020 May; 24(2):525-569. PubMed ID: 31028558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antileishmanial activity of 4-phenyl-1-[2-(phthalimido-2-yl)ethyl]-1H-1,2,3-triazole (PT4) derivative on Leishmania amazonensis and Leishmania braziliensis: In silico ADMET, in vitro activity, docking and molecular dynamic simulations.
    Holanda VN; Silva WVD; Nascimento PHD; Silva SRB; Cabral Filho PE; Assis SPO; Silva CAD; Oliveira RN; Figueiredo RCBQ; Lima VLM
    Bioorg Chem; 2020 Dec; 105():104437. PubMed ID: 33339081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complexes of different nitrogen donor heterocyclic ligands with SbCl3 and PhSbCl2 as potential antileishmanial agents against Sb(III)-sensitive and -resistant parasites.
    Lizarazo-Jaimes EH; Reis PG; Bezerra FM; Rodrigues BL; Monte-Neto RL; Melo MN; Frézard F; Demicheli C
    J Inorg Biochem; 2014 Mar; 132():30-6. PubMed ID: 24412095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships and mechanistic studies of novel mitochondria-targeted, leishmanicidal derivatives of the 4-aminostyrylquinoline scaffold.
    Staderini M; Piquero M; Abengózar MÁ; Nachér-Vázquez M; Romanelli G; López-Alvarado P; Rivas L; Bolognesi ML; Menéndez JC
    Eur J Med Chem; 2019 Jun; 171():38-53. PubMed ID: 30904756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antileishmanial compounds from Cordia fragrantissima collected in Burma (Myanmar).
    Mori K; Kawano M; Fuchino H; Ooi T; Satake M; Agatsuma Y; Kusumi T; Sekita S
    J Nat Prod; 2008 Jan; 71(1):18-21. PubMed ID: 18088097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive review of chalcone derivatives as antileishmanial agents.
    de Mello MVP; Abrahim-Vieira BA; Domingos TFS; de Jesus JB; de Sousa ACC; Rodrigues CR; Souza AMT
    Eur J Med Chem; 2018 Apr; 150():920-929. PubMed ID: 29602038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antileishmanial activity of quinazoline derivatives: synthesis, docking screens, molecular dynamic simulations and electrochemical studies.
    Mendoza-Martínez C; Galindo-Sevilla N; Correa-Basurto J; Ugalde-Saldivar VM; Rodríguez-Delgado RG; Hernández-Pineda J; Padierna-Mota C; Flores-Alamo M; Hernández-Luis F
    Eur J Med Chem; 2015 Mar; 92():314-31. PubMed ID: 25576738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Aryl-quinazolin-4(3H)-ones as an inhibitor of leishmania folate pathway: In vitro biological evaluation, mechanism studies and molecular docking.
    Romero AH; Rodríguez N; Oviedo H
    Bioorg Chem; 2019 Mar; 83():145-153. PubMed ID: 30359795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Evaluation of Thiochroman-4-One Derivatives as Potential Leishmanicidal Agents.
    Vargas E; Echeverri F; Vélez ID; Robledo SM; Quiñones W
    Molecules; 2017 Nov; 22(12):. PubMed ID: 29186046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Amino-thiophene derivatives present antileishmanial activity mediated by apoptosis and immunomodulation in vitro.
    Rodrigues KA; Dias CN; Néris PL; Rocha Jda C; Scotti MT; Scotti L; Mascarenhas SR; Veras RC; de Medeiros IA; Keesen Tde S; de Oliveira TB; de Lima Mdo C; Balliano TL; de Aquino TM; de Moura RO; Mendonça Junior FJ; de Oliveira MR
    Eur J Med Chem; 2015 Dec; 106():1-14. PubMed ID: 26513640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and leishmanicidal activity of eugenol derivatives bearing 1,2,3-triazole functionalities.
    Teixeira RR; Gazolla PAR; da Silva AM; Borsodi MPG; Bergmann BR; Ferreira RS; Vaz BG; Vasconcelos GA; Lima WP
    Eur J Med Chem; 2018 Feb; 146():274-286. PubMed ID: 29407957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, antileishmanial activity and mechanism of action studies of novel β-carboline-1,3,5-triazine hybrids.
    Baréa P; Barbosa VA; Bidóia DL; de Paula JC; Stefanello TF; da Costa WF; Nakamura CV; Sarragiotto MH
    Eur J Med Chem; 2018 Apr; 150():579-590. PubMed ID: 29549842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, biological activity, and mechanism of action of new 2-pyrimidinyl hydrazone and N-acylhydrazone derivatives, a potent and new classes of antileishmanial agents.
    Coimbra ES; Nora de Souza MV; Terror MS; Pinheiro AC; da Trindade Granato J
    Eur J Med Chem; 2019 Dec; 184():111742. PubMed ID: 31605866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and in vitro biological evaluation of novel thiazolopyrimidine derivatives as antileishmanial compounds.
    Istanbullu H; Bayraktar G; Akbaba H; Cavus I; Coban G; Debelec Butuner B; Kilimcioglu AA; Ozbilgin A; Alptuzun V; Erciyas E
    Arch Pharm (Weinheim); 2020 Aug; 353(8):e1900325. PubMed ID: 32484266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.